Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

Greater screening can help improve colorectal cancer rates among Hispanic men in California

Greater screening can help improve colorectal cancer rates among Hispanic men in California

Study finds high rates of increasing obesity in patients with history of cancer

Study finds high rates of increasing obesity in patients with history of cancer

Early and late menopause linked to increased risk of developing type 2 diabetes

Early and late menopause linked to increased risk of developing type 2 diabetes

Adhesive patch can deliver triple combination therapy to tumor sites

Adhesive patch can deliver triple combination therapy to tumor sites

Blood cancer is associated with considerably higher healthcare costs than other cancers

Blood cancer is associated with considerably higher healthcare costs than other cancers

Bowel Cancer UK conducts two free Colorectal Cancer Study Days for healthcare professionals

Bowel Cancer UK conducts two free Colorectal Cancer Study Days for healthcare professionals

Researchers identify unique mechanism to suppress colorectal cancer tumors in mice

Researchers identify unique mechanism to suppress colorectal cancer tumors in mice

NorthShore launches first clinical trial to examine GRS test for cancer risk assessment

NorthShore launches first clinical trial to examine GRS test for cancer risk assessment

Research shows biglycan molecule plays key role in determining tumour malignancy

Research shows biglycan molecule plays key role in determining tumour malignancy

Review highlights interconnected roles of apoptosis, cellular senescence in cancer and aging

Review highlights interconnected roles of apoptosis, cellular senescence in cancer and aging

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Recellularized colon model helps identify cancer driver genes involved in CRC progression

Recellularized colon model helps identify cancer driver genes involved in CRC progression

Research opens up new ways to detect, inhibit cancer spread

Research opens up new ways to detect, inhibit cancer spread

Tumor DNA fragments in blood can help identify risk of colorectal cancer recurrence

Tumor DNA fragments in blood can help identify risk of colorectal cancer recurrence

New ESMO guidelines reflect personalized approach for management of metastatic colorectal cancer

New ESMO guidelines reflect personalized approach for management of metastatic colorectal cancer

Scientists identify genetic mutations linked to synchronous colorectal cancers

Scientists identify genetic mutations linked to synchronous colorectal cancers

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Study shows low incidence of cancer in patients with large colorectal polyps

Study shows low incidence of cancer in patients with large colorectal polyps

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.